Antianemia Drug Receives Boxed Warning

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 115, Nº. 8, 2015, págs. 48-48
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * A new boxed warning and a new contraindication are being added to the labeling of ferumoxytol (Feraheme). The boxed warning states that there is a risk of anaphylaxis and even death with ferumoxytol infusion.

    * The new contraindication to use is a previous allergic reaction to ferumoxytol or any other IV iron-replacement drug.